Role of ceruloplasmin and ascorbate in cellular iron release

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 5, 1999, Pages 454-465

  Richardson, Des R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033231215     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90166-X     Document Type: Article

References (56)

1. 1. Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1997;1331:1-40.
2. 2. Lynch SR, Lipschitz DA, Bothwell TH, Charlton RW. Iron and the reticuloendothelial system. In: Jacobs A, Worwood M, editors. Iron in biochemistry and medicine. New York: Academic Press; 1974. p. 563-87.
3. 3. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal ion transporter. Nature 1997;388:482-8.
4. 4. Fleming MD, Trenor CCI, Su MA, Foernzler D, Beier DR, Dietrich WF, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-6.
5. 5. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RTA, Gitlin JD. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995;92:2539-43.
6. 6. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995;9:267-72.
7. 7. Kaplan J, O'Halloran TV. Iron metabolism in eukaryotes: Mars and Venus at it again. Science 1996;271:1510-2.
8. 8. Ragan HA, Nacht S, Lee GR, Bishop CR, Cartwright GE. Effect of ceruloplasmin on plasma iron in copper-deficient swine. Am J Physiol 1969;217:1320-3.
9. 9. Osaki S, Johnson DA. Mobilization of liver iron by ferroxidase (ceruloplasmin). J Biol Chem 1969;244:5757-8.
10. 10. Roeser HP, Lee GR, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest 1970;49:2408-17.
11. 11. Osaki S, Johnson DA, Frieden E. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J Biol Chem 1971;246:3018-23.
12. 12. Osaki S, Johnson DA, Frieden E. The possible significance of ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966;241:2746-51.
13. 13. Mukhopadhyay CK, Attieh ZK, Fox PL. Role of ceruloplasmin in cellular iron uptake. Science 1998;279:714-7.
14. 14. Yuan DS, Stearman R, Dancis A, Dunn T, Beeler T, Klausner RD. The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake. Proc Natl Acad Sci USA 1995;92:2632-6.
15. 15. Attieh ZK, Mukhopadhyay CK, Seshadri V, Tripoulas NA, Fox PL. Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem 1999;274:1116-23.
16. 16. Schen RJ, Rabinovitz M. Differential staining of ceruloplasmin as an aid to interpretation in immunoelectrophoresis. Clin Chim Acta 1966;13:537-8.
17. 17. Richardson DR, Milnes K. The potential of analogues of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Blood 1997;89:3025-38.
18. 18. Richardson DR, Baker E. The uptake of iron and transferrin by the human malignant melanoma cell. Biochim Biophys Acta 1990;1053:1-12.
19. 19. Richardson DR, Baker E. Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate. J Biol Chem 1992;267:13972-9.
20. 20. Richardson DR, Baker E. The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells. Biochim Biophys Acta 1992;1103:275-80.
21. 21. Richardson DR, Chua A, Baker E. Activation of an iron-transport mechanism from transferrin in hepatocytes by preincubation with low molecular weight iron complexes. J Lab Clin Med 1999;133:144-51.
22. 22. Müllner EW, Kühn LC. A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin mRNA stability in the cytoplasm. Cell 1988;53:815-25.
23. 23. Müllner EW, Neupert B, Kühn LC. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 1989;58:373-82.
24. 24. Pantopoulos K, Gray N, Hentze MW. Differential regulation of two related RNA-binding proteins, iron regulatory protein (IRP) and IRPB. RNA 1995;1:155-63.
25. 25. Pantopoulos K, Weiss G, Hentze MW. Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol 1996;16:3781-8.
26. 26. Morgan EH. Chelator-mediated iron efflux from reticulocytes. Biochim Biophys Acta 1983;733:39-50.
27. 59Fe. Biochim Biophys Acta 1983;757:306-15.
28. 28. Lipschitz DA, Bothwell TH, Seftel HC, Wapnick AA, Chadton RW. The role of ascorbic acid in the metabolism of storage iron. Br J Haematol 1971;20:155-63.
29. 29. Toth I, Bridges KR. Ascorbic acid enhances ferritin mRNA translation by an IRP/aconitase switch. J Biol Chem 1995;270:19540-4.
30. 30. Toth I, Rogers JT, McPhee JA, Elliott SM, Abramson SL, Bridges, KR. Ascorbic acid enhances iron-induced ferritin translation in human leukemia and hepatoma cells. J Biol Chem 1995;270:2846-52.
31. 31. Hershko C, Weatherall DJ. Iron chelating therapy. Crit Rev Clin Lab Sci 1988;26:303-45.
32. 32. Iacopetta BJ, Morgan EH. The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes. J Biol Chem 1983;258:9108-15.
33. 33. Morgan EH, Baker E. The effect of metabolic inhibitors on transferrin and iron uptake and transferrin release from reticulocytes. Biochim Biophys Acta 1969;184:442-54.
34. 34. Kailis SG, Morgan EH. Iron uptake by immature erythroid cells. Mechanism of dependence on metabolic energy. Biochim Biophys Acta 1997;464:389-98.
35. 35. Richardson DR. Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process. Biochim Biophys Acta 1997;1320:45-57.
36. 36. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
37. 37. Böhme M, Büchler M, Müller M, Keppler D. Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 1993;333:193-6.
38. 38. Lehninger AL. Biochemistry. 2nd ed. New York: Worth Publishers Inc; 1981. p. 351.
39. 39. Bottomley SS, Wolfe LC, Bridges KR. Iron metabolism in K562 erythroleukemia cells. J Biol Chem 1985;260:6811-5.
40. 40. Kaplan J, Jordan I, Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 1991;266:2997-3004.
41. 41. Inman RS, Wessling-Resnick M. Characterization of transferrin-independent iron transport in K562 cells. J Biol Chem 1993;268:8521-8.
42. 42. Morgan EH. Transferrin biochemistry, physiology and clinical significance. Mol Aspects Med 1981;4:1-123.
43. 43. Lee GR, Nacht S, Lukens JN, Cartwright GE. Iron metabolism in copper-deficient swine. J Clin Invest 1968;47:2058-69.
44. 44. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GPR. Hereditary ceruloplasmin deficiency, dementia and diabetes mellitus. QJM 1994;87:663-70.
45. 45. Osaki S. Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin). J Biol Chem 1966;241:5053-9.
46. 46. Young SP, Fahmy M, Golding S. Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells. FEBS Lett 1997;411:93-6.
47. 47. Bates GW, Schlabach MR. The reaction of ferric salts with transferrin. J Biol Chem 1973;48:3228-32.
48. 48. Baker E, Morton AG, Tavill AS. The regulation of iron release from the perfused rat liver. Br J Haematol 1980;45:607-20.
49. 49. Baker E, Vicary FR, Huehns ER. Iron release from rat hepatocytes in culture. Br J Haematol 1981;47:493-504.
50. 50. Baker E, Page M, Morgan EH. Transferrin and iron release from rat hepatocytes in culture. Am J Physiol 1985;248:G93-7.
51. 51. Mercer JFB, Livingston J, Hall B, Paynter JA, Begy C, Chandrasekharappa S, et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet 1993;3:20-5.
52. 52. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 1993;3:7-13.
53. 53. Camakaris J, Petris MJ, Bailey L, Shen P, Lockhart P, Glover, TW, et al. Gene amplification of the Menkes (MNK; ATP7A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux. Hum Mol Genet 1995;4:2117-23.
54. 54. Copstead L-EC. Perspectives on pathophysiology. Philadelphia: WB Saunders; 1995.
55. 55. Zimmer G, Schirmer H. Viscosity changes of crythrocyte membrane and membrane lipids at transition temperature. Biochim Biophys Acta 1974;345:314-20.
56. 56. Crichton RR, Roman F, Roland F, Doyen C, Mareschal J-C. Iron release from ferritin in vitro and in vivo by iron chelators. In: Martell AE, Anderson WF, Badman DG, editors. Development of iron chelators for clinical use. New York: Elsevier/North-Holland; 1981. p. 265-6.